Skip to content
★ Sign in to follow
FD

Filip Dubovsky

Novavax Inc
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€795k

Latest filing published 20 Jun 2024 for NOVAVAX INC, €9,111.

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Filip Dubovsky: trading record in brief

Filip Dubovsky is a declared insider of Novavax Inc, with filings sourced from SEC (Form 4). Between 16 June 2023 and 17 June 2024, the trades on record add up to 18 filings.

Sales make up the whole of the open-market record (3 sales, €795k). Besides market trades, the filings include 6 share grants and 9 option exercises. In 2024 alone, the filings show no purchases and 3 sales.

Most recently, on 20 June 2024, the filings show an option exercise worth €71k in Novavax Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Filip Dubovsky

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ◇
    President, R&DExecutivesNovavax Inc
    9,786 USD22SEC
    1,404 shares@ US$6.973.2% of flowCommon StockSEC:0001593968-24-000879:0
  • ◇
    President, R&DExecutivesNovavax Inc
    136,974 USD26SEC
    19,652 shares@ US$6.9744.9% of flowCommon StockSEC:0001104659-24-062148:0
  • ◇
    President, R&DExecutivesNovavax Inc
    0SEC
    5,376 sharesCommon StockSEC:0001104659-24-033620:0
  • ◇
    President, R&DExecutivesNovavax Inc
    0SEC
    19,444 sharesCommon StockSEC:0001104659-24-033165:0
  • ◇
    President, R&DExecutivesNovavax Inc
    16,120 USD23SEC
    2,833 shares@ US$5.695.3% of flowCommon StockSEC:0001209191-23-058982:0
  • ◇
    President, R&DExecutivesNovavax Inc
    9,884 USD22SEC
    1,400 shares@ US$7.063.3% of flowCommon StockSEC:0001209191-23-054625:0
  • ◇
    President, R&DExecutivesNovavax Inc
    97,485 USD25SEC
    12,644 shares@ US$7.7132.5% of flowCommon StockSEC:0001209191-23-050009:0
  • ◇
    President, R&DExecutivesNovavax Inc
    33,406 USD23SEC
    4,155 shares@ US$8.0410.8% of flowCommon StockSEC:0001209191-23-038804:0

8 of 8 declarations